The effect of maternal viral load on the risk of perinatal transmission of HIV-1

AIDS

Volumn 11, Issue 4, 1997, Pages 437-444

  Thea, Donald M ^a,h   Steketee, Richard W ^c   Pliner, Vadim ^a   Bornschlegel, Katherine ^b   Brown, Teresa ^c   Orloff, Sherry ^c   Matheson, Pamela B ^a   Abrams, Elaine J ^d   Bamji, Mahrukh ^e   Lambert, Genevieve ^f   Schoenbaum, Ellie A ^g   Thomas, Pauline A ^b   Heagarty, Margaret ^d   Kalish, Marcia L ^c  

^a Medical and Health Research Association   (United States)

^b NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d HARLEM HOSPITAL CENTER   (United States)

^e METROPOLITAN HOSPITAL CENTER   (United States)

^f BRONX LEBANON HOSPITAL CENTER   (United States)

^g ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^h Box 044   (United States)

Author keywords

Children; HIV 1; Nucleic acid sequence based amplification; Perinatal transmission; Viral load

Indexed keywords

CD4 ANTIGEN; VIRUS RNA;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; PERINATAL PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; UNITED STATES; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

EID: 8044258355     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199704000-00006     Document Type: Article

References (39)

1. World Health Organization: Current and Future Dimensions of the HIV-1 AIDS Pandemic: A Capsule Summary. [WHO-GPA 1992, WHO/GPA/RES/SFI/92.1] . Geneva: LOHO/GPA; 1992.
2. Gwinn ML, Pappaioanou M, George JR, et al.: Prevalence of HIV infection in childbearing women in the United States. Surveillance using newborn blood samples. JAMA 1991, 265:1704-1708.
3. Connor EM, Sperling RS, Gelber RD, et al.: Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994, 331:1173-1180.
4. Cao Y, Ho DD, Todd J, et al.: Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma. AIDS Res Hum Retrovirus 1995, 11:353-361.
5. Piatak Jr M, Saag MS, Yang LC, et al.: High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993, 259:1749-1754.
6. Bruisten S, Gemen BV, Koppelman M, et al.: Detection of HIV-1 distribution in different blood fractions by two nucleic acid amplification assays. AIDS Res Hum Retrovirus 1993, 9:259-265.
7. Lafeuillade A, Tamalet C, Pellegrino P, de Micco P, Vignoli C, Quifichini R: Correlation between surrogate markers, viral load, and disease progression in HIV-1 infection. J Acquir Immune Defic Syndr 1994, 7:1028-1033.
8. Lin HJ, Myers LE, Yen-Lieberman B, et al.: Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA. J Infect Dis 1994, 170:553-562.
9. Dewar RL, Highbarger HC, Sarmiento MD, et al.: Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma. J Infect Dis 1994, 170:1172-1179.
10. Papaevangelou V, Moore T, Nagaraj V, Krasinski K, Borkowsky W: Lack of predictive value of maternal human immunodeficiency virus p24 antigen for transmission of infection to their children. Pediater Infact Dis J 1992, 11:851-855.
11. Scarlatti G, Lombardi V, Plebani A, et al.: Polymerase chain reaction, virus isolation and antigen assay in HIV-1 -antibody-positive mothers and their children. AIDS 1991, 5:1173-1178.
12. Cao Y, Qin L, Zhang L, Safrit J, Ho DD: Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995, 332:201-208.
13. Kievits T, Gemen BV, Strijp DV, et al.: NASBA™ isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 Infection. J Virol Methods 1991, 35:273-286.
14. Thomas PA, Weedon J, Krasinski K, et al.: Maternal predictors of perinatal human immunodeficiency virus transmission. The New York City Perinatal HIV Transmission Collaborative Study Group. Pediatr Infect Dis J 1994, 13:489-495.
15. Rogers MF, Ou CY, Rayfield M, et al.: Use of the polymerase chain reaction for early detection of the proviral sequences of human immunodeficiency virus in infants born to seropositive mothers. New York City Collaborative Study of Maternal HIV Transmission and Montefiore Medical Center HIV Perinatal Transmission Study Group. N Engl J Med 1989, 320:1649-1654.
16. Centers for Disease Control: Classification system for human immunodeficiency virus infection in children under 13 years of age. MMWR 1987, 36:225-236.
17. Winters MA, Tan LB, Katzenstein DA, Merigan TC: Biological variation and quality control of plasma human immunodeficiency virus type 1 RNA quantitation by reverse transcriptase polymerase chain reaction. J Clin Microbiol 1993, 31:2960-2966.
18. Saag MS, Crain MJ, Decker WD, et al.: High-level viremia in adults and children infected with human immunodeficiency virus: relation to disease stage and CD4+ lymphocyte levels. J Infect Dis 1991, 164:72-80.
19. Lefrere J, Mariotti M, Wattel E, et al.: Towards a new predictor of AIDS progression through the quantification of HIV-1 DNA copies by PCR in HIV-infected individuals. Br J Haematol 1992, 82:467-471.
20. Piatak M Jr, Saag MS, Yang LC, et al.: Determination of plasma viral load in HIV-1 infection by quantitative competitive polymerase chain reaction. AIDS 1993, 7 (suppl 2):S65-S71.
21. Saag MS, Hammer SM, Lange JM: Pathogenicity and diversity of HIV and implications for clinical management: a review. J Acquir Immune Defic Syndr 1994, 7 (suppl 2):S2-S10.
22. The European Collaborative Study: Risk factors for mother-to-child transmission of HIV-1. European Collaborative Study Lancet 1992, 339:1007-1012.
23. Lepage P, Dabis F, Hitimana D-G, et al.: Perinatal transmission of HIV-1: lack of impact of maternal HIV infection on characteristics of livebirths and on neonatal mortality in Kigali, Rwanda. AIDS 1991, 5:295-300.
24. Compton J: Nucleic acid sequence-based amplification. Nature 1991, 350:91-92.
25. Centers for Disease Control: 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992, 41 (RR-17):1-19.
26. Graziosi C, Pantaleo G, Butini L, et al.: Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection. Proc Natl Acad Sci USA 1993, 90:6405-6409.
27. Palasanthiran P, Ziegler JB, Stewart GJ, et al.: Breast-feeding during primary maternal human immunodeficiency virus infection and risk of transmission from mother to infant. J Infect Dis 1993, 167:441-444.
28. Scarlatti G, Hodara V, Rossi P, et al.: Transmission of human immunodeficiency virus type 1 (HIV-1) from mother to child correlates with viral phenotype. Virology 1993, 197:624-629.
29. Kliks SC, Wara DW, Landers DV, Levy JA: Features of HIV-1 that could influence maternal-child transmission. JAMA 1994, 274:467-474.
30. Scarlatti G, Leitner T, Hodara V, et al.: Neutralizing antibodies and viral characteristics in mother-to-child transmission of HIV-1. AIDS 1993, 7 (suppl 2):S45-S48.
31. Weiser B, Nachman S, Tropper P, et al.: Quantitation of human immunodeficiency virus type 1 during pregnancy: relationship of viral titer to mother-to-child transmission and stability of viral load. Prix Natl Acad Sci USA 1994, 91:8037-8041.
32. Borkowsky W, Krasinski K, Cao Y, et al.: Correlation of perinatal transmission of human immunodeficiency virus type 1 with maternal viremia and lymphocyte phenotypes. J Pediatr 1994, 125:345-351.
33. Dickover RE, Garratty E, Herman SA, et al.: Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. JAMA 1996, 275:599-605.
34. Burchett SK, Kornegay J, Pitt J, et al.: Assessment of maternal plasma HIV viral load as a correlate of vertical transmission. Third National Conference on Human Retroviruses. Washington, DC, January-February 1996 [abstract LB3].
35. Shaffer N, Chotpitayasunondh T, Roongipisuthipong A, et al.: High maternal viral load predicts perinatal HIV-1 transmission and early infant progression. Third National Conference on Human Retroviruses. Washington, DC, January-February 1996 [abstract 30].
36. Sperling RS, Shapiro DE, Coombs R, et al.: Maternal plasma HIV-1 RNA and the success of zidovudine (ZDV) in the prevention of mother-child transmission. Third National Conference on Human Retroviruses. Washington, DC, January-February 1996 [abstract LB1].
37. Klebanoff SI, Coombs RW: Viricidal effect of polymorphonuclear leukocytes on human immunodeficiency virus-1. Role of the myeloperoxidase system. J Clin Invent 1992, 89:2014-2017.
38. Mole LA, Margolis D, Carroll R, Todd J, Holodniy M: Stabilities of quantitative plasma culture for human immunodeficiency virus, RNA and p24 antigen from samples collected in vacutainer CPT and standard Vacutainer tubes. J Clin Microbiol 1994, 32:2212-2215.
39. Holodniy M, Mole LA, Yen-Lieberman B, et al.: Comparative stabilities of quantitative human immunodeficiency virus RNA in plasma from samples collected in Vacutainer CPT, Vacutainer PPT, and standard Vacutainer tubes. J Clin Microbiol 1995, 33:1562-1566.